Synovial chondromatosis in a child’s thumb: a case report and review of the literature
- First Online:
- Cite this article as:
- Gottschalk, H.P., Newbury, R. & Wallace, C.D. HAND (2012) 7: 98. doi:10.1007/s11552-011-9376-y
- 54 Views
Primary synovial chondromatosis consists of cartilaginous metaplasia of the synovium, which leads to the production of intra-articular and periarticular osteocartilaginous bodies [8, 12, 18, 19]. The nomenclature has evolved with time to include chondromatosis of the joint capsule, diffuse enchondroma of the joint capsule, joint chondroma, synovial osteochondromatosis, and synovial chondromatosis [8, 9, 16, 18, 20]. Primary synovial chondromatosis most commonly occurs in young and middle-aged adults and is rarely found in children (youngest patient reported was 14 years old) [12, 19]. The entity usually involves the synovium of large joints (knee, hip, elbow, and shoulder) [3, 8, 15, 16, 18, 19, 26] but has been reported in the hand [2, 10–12, 20, 26]. To our knowledge, only two cases have been reported in the interphalangeal joint of the thumb [13, 14]. We report on a 13-year-old female with primary synovial chondromatosis of the inter-phalangeal (IP) joint of her thumb.
A 13-year-old right-hand dominant female presented with a 3-year history of pain and progressive swelling over the dorsum of her right thumb. She was initially seen by an adult hand surgeon for this mass, and because of her lack of symptoms at that time, she was observed. She gave no history of trauma and no other relevant medical history. On examination, several masses were located both on the dorsal and volar aspects of the thumb IP joint. The masses were focally tender and had a firm and nodular consistency. Range of motion was almost normal at the joint.
Physical therapy for range of motion was initiated 3 weeks after surgery. Three months after surgery, she had painless range of motion with full extension, but lacking 10° of full flexion. No recurrence was noted at 6 months post surgery.
Primary synovial chondromatosis is an uncommon condition characterized by benign metaplasia of synovial tissue into cartilaginous tissue [2, 8, 10, 18, 20]. The exact etiology of synovial chondromatosis remains unclear, but this primary form can originate from synovium or tenosynovium [4, 18, 20]. The tenosynovial form may be caused by trauma, in contrast to “intra-articular” chondromatosis, which has no such association [8, 12, 22].
These two entities are distinct from the more common secondary synovial chondromatosis, which occurs with the implantation of cartilage fragments into the tissue as a result of degenerative disease (osteoarthritis), neuropathic arthropathy, or trauma [1, 20, 26].
Males are affected more than females, commonly ranging in age from the third to fifth decade of life [3, 12, 13, 18]. Typically large joints are involved with the knee being the most common, followed by the hip and elbow [3, 8, 15, 16, 18, 19, 26]. This disease has been documented in the joints of the hand, specifically the metacarpophalangeal joint [2, 7, 11, 20, 22, 23, 26] and interphalangeal joint [6, 10, 12–14, 25]. Only two of these cases involved the thumb interphalangeal joint [13, 14]. When synovial chondromatosis occurs in the smaller joints, it has a predilection towards young women in contrast to that of the larger joints [12, 14].
The articular form of primary synovial chondromatosis can slowly progress, and patients will have symptoms present for months to years [8, 12]. Common presenting complaints include pain, swelling, and restriction of motion. Milgram described three separate phases: (1) active intrasynovial disease with no free loose bodies; (2) transitional lesions with osteochondral nodules in the synovial membrane and osteochondral bodies lying free within the joint cavity; and (3) multiple free osteochondral bodies, with now quiescent intrasynovial disease . This patient likely had an initial presentation in the early phase (soft tissue swelling but no pain), and her symptoms worsened as she progressed to the transitional phase. The natural history of this condition is not well known. Milgram has described cases where some of the nodules have been resorbed spontaneously and not extruded into the joint . However, if extra-capsular chondromatous lesions are present, then the lesions seem to behave more like a neoplasm versus a reactive process and surgical intervention is recommended.
Malignant transformation of this disease into synovial chondrosarcoma is exceedingly rare [8, 12, 15, 18], but Davis et al. have reported a risk of malignant change of 5% (3 of 53 patients) . As with other case reports on malignant transformation, all of these cases were in large joints [3, 5, 17, 21, 24]. To our knowledge, no cases of malignant transformation have been seen in the finger joints.
Controversy remains regarding the extent of surgical treatment for primary synovial chondromatosis. The debate centers on preventing recurrence of the disease. Murphy et al. advocated removal of loose bodies with synovectomy. They stated that the synovium “nourishes” the loose bodies which can remain viable and increase in size . In contrast, Jeffreys recommended removal of loose bodies alone, with no recurrences reported . The recurrence rate has been reported as high as 15%; however, most of these cases involved large joints [3, 15]
Three cases of recurrence have been reported in the hand (two interphalangeal joints and one metacarpophalangeal joint) [6, 11, 12]. Other authors recommend that synovectomy should be done only if pain and swelling are the main symptoms. If mechanical symptoms predominate, then removal of loose bodies alone may be sufficient [12, 15]. Since recurrence has been noted even after synovectomy (4 years later) [6, 12], we recommend that patients be counseled in this regard and offered periodic follow-ups to detect for recurrence.
Conflicts of Interest
No pharmaceutical, industry, or outside support was used for this study. The authors report no conflicts of interest. No funding was received for this work from any of the following organizations: NIH, Wellcome Trust, Howard Hughes Medical Institute, and others.